NCT07212439 Monitoring Coughs for the Early Detection of Worsening COPD
| NCT ID | NCT07212439 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clinica Universidad de Navarra, Universidad de Navarra |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-10-29 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-10-29 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is for adults with COPD. Flare-ups of COPD, also known as exacerbations, can be serious and lead to hospital stays. The purpose of this research is to see if continuously and automatically monitoring a person's coughs can help predict these flare-ups early, before they become severe. Participants will use the Hyfe cough monitoring system, which includes a watch-like device worn on the wrist and a smartphone application. The system privately counts the number of coughs without recording any audio. Participants will also answer a short, weekly questionnaire about their COPD symptoms. This is an observational study, which means it will not change the regular medical care a participant receives. The participants and their care providers will not see the cough counts. The doctor will continue to manage their COPD as usual.
Eligibility Criteria
Inclusion criteria: * Must be 18 years of age or older. * Must have an existing diagnosis of COPD. * For the inpatient cohort, participants must be currently assessed as having a moderate/severe exacerbation. * For the outpatient cohort, participants must have had at least one exacerbation of any severity in the last 12 months. * For the outpatient cohort, at least one month must have passed since the last exacerbation. Exclusion criteria: * Individuals who are unable to provide informed consent. * Individuals who are unable to adhere to study procedures. * For the inpatient cohort, individuals requiring invasive or non-invasive ventilation. * Individuals who live with a person who has a chronic cough.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07212439 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07212439 currently recruiting?
Yes, NCT07212439 is actively recruiting participants. Contact the research team at cchaccour@unav.es for enrollment information.
Where is the NCT07212439 trial being conducted?
This trial is being conducted at Pamplona, Spain, Pamplona, Spain, Pamplona, Spain.
Who is sponsoring the NCT07212439 clinical trial?
NCT07212439 is sponsored by Clinica Universidad de Navarra, Universidad de Navarra. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.